ID: ALA288568

Max Phase: Preclinical

Molecular Formula: C22H18O3

Molecular Weight: 330.38

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1ccc(Cc2ccc3c(c2O)C(=O)c2c(O)cccc2C3)cc1

Standard InChI:  InChI=1S/C22H18O3/c1-13-5-7-14(8-6-13)11-17-10-9-16-12-15-3-2-4-18(23)19(15)22(25)20(16)21(17)24/h2-10,23-24H,11-12H2,1H3

Standard InChI Key:  CSOOAFUQMXDQNY-UHFFFAOYSA-N

Associated Targets(non-human)

Arachidonate 5-lipoxygenase 259 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 330.38Molecular Weight (Monoisotopic): 330.1256AlogP: 4.13#Rotatable Bonds: 2
Polar Surface Area: 57.53Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.51CX Basic pKa: CX LogP: 6.85CX LogD: 6.82
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.58Np Likeness Score: 0.69

References

1. Müller K, Leukel P, Ziereis K, Gawlik I..  (1994)  Antipsoriatic anthrones with modulated redox properties. 2. Novel derivatives of chrysarobin and isochrysarobin--antiproliferative activity and 5-lipoxygenase inhibition.,  37  (11): [PMID:8201600] [10.1021/jm00037a017]

Source